ArticleAging pathobiology and therapeutics2022
Microbiome in aging of Gut and Brain (MiaGB): paving the ways to understand gut-brain axis in aging.
Article in Aging pathobiology and therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Article
- The selection of participants for interventional microbiota trials involving cognitively impaired older adults.GeroScience · 2025Review
- Unique trans-kingdom microbiome structural and functional signatures predict cognitive decline in older adults.GeroScience · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 2 countries.
Funding
Abstract
Decades of aging research established several well-characterized theories of aging, yet as the studies often focus on different cellular mechanisms there is overall agreement that organismal aging is characterized by multi-factorial degenerative processes resulting from multiple alterations of different molecular pathways compromising cellular or tissues functions. Due to this complexity aging is a major risk factor for multiple diseases including cardiovascular diseases, cancers, diabetes, and neurological diseases such as Alzheimer's disease. It is well known that this multi-factorial process in some cases might be accelerated by the dysfunction of one organ as a source of chronic low-grade inflammation. Importantly, most recent studies provide strong evidence that the gut microbiome represents a new independent organ system mainly composed of a variety of microorganisms recognized as the microbiome. The high integrity of the microbiome with the host physiology and biochemical interactions between specific bacteria and cellular processes supports its organ-like function in organismal health and the process of aging. However, it is important to better understand what causes potential cellular stress to accelerate a variety of pathological changes, what is the specific role of our gut microbiome in process of human aging, and how we could use this knowledge to prevent or delay aging pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.